QNCX
Quince Therapeutics, Inc. (QNCX) is currently trading at $1.80, down $0.20 (10%) from the previous close.
This decline may be influenced by the company’s recent financial performance. In the third quarter of 2024, Quince Therapeutics reported a net loss of $53.12 million. 
Additionally, the company has been involved in legal proceedings, including a class-action lawsuit alleging violations of securities regulations. Such legal challenges can negatively impact investor sentiment and stock performance.
It’s important to note that stock prices are influenced by various factors, including company performance, legal issues, and overall market conditions. For the most accurate and up-to-date information, consider consulting financial news sources or a financial advisor.
No comments:
Post a Comment